International normalized ratio (INR) is the preferred test of choice for patients taking vitamin
K antagonists (VKA). It can also be used to assess the risk of bleeding or the coagulation …

The Prothrombin Time (PT) test is used for monitoring of treatment with Vitamin K-
antagonists (VKA). The result of the PT test should be expressed as the International …

Although the landscape of anticoagulation therapy is evolving, vitamin K antagonists (VKAs)
such as warfarin remain an anticoagulant of choice for many clinicians and their patients …

The Quick prothrombin time is the most common clotting test performed, principally for
monitoring oral anticoagulant therapy. The International Normalized Ratio (INR) for …

The prothrombin time (PT) assay is the most clinically ordered coagulation test and is most
often used for monitoring of vitamin K antagonist (VKA) therapy (eg, warfarin), where results …

The monitoring of warfarin therapy using the international normalized ratio (INR) has now
moved outside the laboratory's control by use of point-of-care (POC) devices. Although this …

The prothrombin time (PT) assay is the most often requested coagulation test and used
primarily for monitoring Vitamin K antagonist therapy, where results may be expressed as an …

Within each patient treated with vitamin K antagonist (VKA), variation of the international
normalised ratio (INR) occurs over the treatment period. The purpose of the present study …

Vitamin K antagonists (VKAs) are effective oral anticoagulants that are titrated to a narrow
therapeutic international normalized ratio (INR) range. We reviewed published literature …

Until recently, vitamin K antagonists (VKAs) were the mainstay of oral anticoagulant
treatment with bleeding as the most prevalent adverse effect. One to four percent of patients …